Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Author Correction: Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo.

Heinemann FM, Jindra PT, Bockmeyer CL, Zeuschner P, Wittig J, Höflich H, Eßer M, Abbas M, Dieplinger G, Stolle K, Vester U, Hoyer PF, Immenschuh S, Heinold A, Horn PA, Li W, Eisenberger U, Becker JU.

Sci Rep. 2018 Apr 12;8(1):6003. doi: 10.1038/s41598-018-23760-1.

2.

Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma.

Lee HS, Jang HJ, Choi JM, Zhang J, de Rosen VL, Wheeler TM, Lee JS, Tu T, Jindra PT, Kerman RH, Jung SY, Kheradmand F, Sugarbaker DJ, Burt BM.

JCI Insight. 2018 Apr 5;3(7). pii: 98575. doi: 10.1172/jci.insight.98575. [Epub ahead of print]

3.

Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo.

Heinemann FM, Jindra PT, Bockmeyer CL, Zeuschner P, Wittig J, Höflich H, Eßer M, Abbas M, Dieplinger G, Stolle K, Vester U, Hoyer PF, Immenschuh S, Heinold A, Horn PA, Li W, Eisenberger U, Becker JU.

Sci Rep. 2017 Nov 6;7(1):14554. doi: 10.1038/s41598-017-14674-5. Erratum in: Sci Rep. 2018 Apr 12;8(1):6003.

4.

Pediatric Liver Transplantation Across the ABO Blood Group Barrier: Is It an Obstacle in the Modern Era?

Rana A, Kueht ML, Nicholas SK, Jindra PT, Himes RW, Desai MS, Cotton RT, Galvan NT, O'Mahony CA, Goss JA.

J Am Coll Surg. 2016 Apr;222(4):681-9. doi: 10.1016/j.jamcollsurg.2015.12.041. Epub 2016 Jan 30.

PMID:
27016995
5.

Analysis of a Genetic Polymorphism in the Costimulatory Molecule TNFSF4 with Hematopoietic Stem Cell Transplant Outcomes.

Jindra PT, Conway SE, Ricklefs SM, Porcella SF, Anzick SL, Haagenson M, Wang T, Spellman S, Milford E, Kraft P, McDermott DH, Abdi R.

Biol Blood Marrow Transplant. 2016 Jan;22(1):27-36. doi: 10.1016/j.bbmt.2015.08.037. Epub 2015 Sep 5.

6.

Glomerular mRNA expression of prothrombotic and antithrombotic factors in renal transplants with thrombotic microangiopathy.

Agustian PA, Bockmeyer CL, Modde F, Wittig J, Heinemann FM, Brundiers S, Dämmrich ME, Schwarz A, Birschmann I, Suwelack B, Jindra PT, Ahlenstiel T, Wohlschläger J, Vester U, Ganzenmüller T, Zilian E, Feldkamp T, Spieker T, Immenschuh S, Kreipe HH, Bröcker V, Becker JU.

Transplantation. 2013 May 27;95(10):1242-8. doi: 10.1097/TP.0b013e318291a298.

PMID:
23635876
7.

Tolerance to MHC class II disparate allografts through genetic modification of bone marrow.

Jindra PT, Tripathi S, Tian C, Iacomini J, Bagley J.

Gene Ther. 2013 May;20(5):478-86. doi: 10.1038/gt.2012.57. Epub 2012 Jul 26.

8.

Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten.

Jindra PT, Bagley J, Godwin JG, Iacomini J.

J Immunol. 2010 Jul 15;185(2):990-7. doi: 10.4049/jimmunol.1000793. Epub 2010 Jun 14.

9.

Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen.

Tian C, Yuan X, Jindra PT, Bagley J, Sayegh MH, Iacomini J.

Clin Immunol. 2010 Aug;136(2):174-87. doi: 10.1016/j.clim.2010.04.012. Epub 2010 May 8.

10.

MHC class I and integrin ligation induce ERK activation via an mTORC2-dependent pathway.

Jindra PT, Jin YP, Jacamo R, Rozengurt E, Reed EF.

Biochem Biophys Res Commun. 2008 May 2;369(2):781-7. doi: 10.1016/j.bbrc.2008.02.093. Epub 2008 Feb 27.

11.

HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway.

Jindra PT, Jin YP, Rozengurt E, Reed EF.

J Immunol. 2008 Feb 15;180(4):2357-66.

12.

Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts.

Jindra PT, Hsueh A, Hong L, Gjertson D, Shen XD, Gao F, Dang J, Mischel PS, Baldwin WM 3rd, Fishbein MC, Kupiec-Weglinski JW, Reed EF.

J Immunol. 2008 Feb 15;180(4):2214-24.

13.
14.

Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration.

Jindra PT, Zhang X, Mulder A, Claas F, Veale J, Jin YP, Reed EF.

Transplantation. 2006 Jul 15;82(1 Suppl):S33-5.

PMID:
16829793
15.

Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts.

Lepin EJ, Zhang Q, Zhang X, Jindra PT, Hong LS, Ayele P, Peralta MV, Gjertson DW, Kobashigawa JA, Wallace WD, Fishbein MC, Reed EF.

Am J Transplant. 2006 Jul;6(7):1560-71.

16.

Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection.

Jin YP, Jindra PT, Gong KW, Lepin EJ, Reed EF.

Transplantation. 2005 Feb 15;79(3 Suppl):S19-21. Review.

PMID:
15699739
17.

Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells.

Jin YP, Fishbein MC, Said JW, Jindra PT, Rajalingam R, Rozengurt E, Reed EF.

Hum Immunol. 2004 Apr;65(4):291-302.

PMID:
15120184
18.

Sequence selective recognition in the minor groove of dsDNA by pyrrole, imidazole-substituted bis-benzimidazole conjugates.

Reddy PM, Jindra PT, Satz AL, Bruice TC.

J Am Chem Soc. 2003 Jul 2;125(26):7843-8.

PMID:
12823002

Supplemental Content

Loading ...
Support Center